It has been known for decades that it is possible to detect small amounts of extracellular
nucleic acids in plasma and serum of healthy and diseased human beings. The unequivocal …

Colorectal cancer is one of the major causes of cancer‐related death in the Western world.
Patient survival is highly dependent on the tumor stage at the time of diagnosis. Reduced …

Background: Despite different available methods for colorectal cancer (CRC) screening and
their proven benefits, morbidity, and mortality of this malignancy are still high, partly due to …

Detecting and removing high-risk adenomas and early colorectal cancer (CRC) can reduce
mortality of this disease. The noninvasive fecal occult blood test (FOBT; guaiac-based or …

Since the association of circulating DNA level changes with tumor growth was discovered
many attempts have been made to develop the sensitive and robust blood-based tests for …

Colorectal cancer (CRC) is the third most common cancer worldwide and, despite improved
treatments, is still an important cause of cancer-related deaths. CRC encompasses a …

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG,
and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer - PMC …

The presence of small amounts of circulating nucleic acids in plasma and serum (CNAPS) is
not a new finding. The verification that such amounts are significantly increased in cancer …

Abstract Background Approximately 20%–45% of colorectal cancer (CRC) patients
ultimately develop local recurrence or metastasis following curative surgical resection. The …

Background Metastasis is the most frequent cause of treatment failure and death in
colorectal cancer. Early detection of tumors and metastases is crucial for improving …